Literature DB >> 21185108

The Alzheimer's associated 5' region of the SORL1 gene cis regulates SORL1 transcripts expression.

Jeanette J McCarthy1, Sunita Saith, Colton Linnertz, James R Burke, Christine M Hulette, Kathleen A Welsh-Bohmer, Ornit Chiba-Falek.   

Abstract

SORL1 has been identified as a major contributor to late onset Alzheimer's disease (LOAD). We test whether genetic variability in the 5' of SORL1 gene modulates the risk to develop LOAD via regulation of SORL1-messenger ribonucleic acid (mRNA) expression and splicing. Two brain structures, differentially vulnerable to LOAD pathology, were examined in 144 brain samples from 92 neurologically normal individuals. The temporal cortex, which is more susceptible to Alzheimer's pathology, demonstrated ∼2-fold increase in SORL1-mRNA levels in carriers of the minor alleles at single nucleotide polymorphisms (SNPs), rs7945931 and rs2298525, compared with noncarriers. No genetic effect on total-SORL1-mRNA levels was detected in the frontal cortex. However, rs11600875 minor allele was associated with significantly increased levels of exon-2 skipping, but only in frontal cortex. No correlation of SORL1-mRNAs expression was found between frontal and temporal cortexes. Collectively, these indicate the brain region specificity of the genetic regulation of SORL1 expression. Our results suggest that genetic regulation of SORL1 expression plays a role in disease risk and may be responsible for the reported LOAD associations. Further studies to detect the actual pathogenic variant/s are necessary.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21185108      PMCID: PMC3117021          DOI: 10.1016/j.neurobiolaging.2010.10.004

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  30 in total

1.  Gene expression profiling in single cells from the pancreatic islets of Langerhans reveals lognormal distribution of mRNA levels.

Authors:  Martin Bengtsson; Anders Ståhlberg; Patrik Rorsman; Mikael Kubista
Journal:  Genome Res       Date:  2005-10       Impact factor: 9.043

2.  Magnetic resonance imaging traits in siblings discordant for Alzheimer disease.

Authors:  Karen T Cuenco; Robert C Green; J Zhang; Kathryn Lunetta; Porat M Erlich; L Adrienne Cupples; Lindsay A Farrer; Charles DeCarli
Journal:  J Neuroimaging       Date:  2008-07       Impact factor: 2.486

3.  LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease.

Authors:  Sara E Dodson; Marla Gearing; Carol F Lippa; Thomas J Montine; Allan I Levey; James J Lah
Journal:  J Neuropathol Exp Neurol       Date:  2006-09       Impact factor: 3.685

4.  Genetics of gene expression and its effect on disease.

Authors:  Valur Emilsson; Gudmar Thorleifsson; Bin Zhang; Amy S Leonardson; Florian Zink; Jun Zhu; Sonia Carlson; Agnar Helgason; G Bragi Walters; Steinunn Gunnarsdottir; Magali Mouy; Valgerdur Steinthorsdottir; Gudrun H Eiriksdottir; Gyda Bjornsdottir; Inga Reynisdottir; Daniel Gudbjartsson; Anna Helgadottir; Aslaug Jonasdottir; Adalbjorg Jonasdottir; Unnur Styrkarsdottir; Solveig Gretarsdottir; Kristinn P Magnusson; Hreinn Stefansson; Ragnheidur Fossdal; Kristleifur Kristjansson; Hjortur G Gislason; Tryggvi Stefansson; Bjorn G Leifsson; Unnur Thorsteinsdottir; John R Lamb; Jeffrey R Gulcher; Marc L Reitman; Augustine Kong; Eric E Schadt; Kari Stefansson
Journal:  Nature       Date:  2008-03-16       Impact factor: 49.962

5.  Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain.

Authors:  Karrie E Grear; I-Fang Ling; James F Simpson; Jennifer L Furman; Christopher R Simmons; Shawn L Peterson; Frederick A Schmitt; William R Markesbery; Qiang Liu; Julia E Crook; Steven G Younkin; Guojun Bu; Steven Estus
Journal:  Mol Neurodegener       Date:  2009-11-04       Impact factor: 14.195

6.  Loss of apolipoprotein E receptor LR11 in Alzheimer disease.

Authors:  Clemens R Scherzer; Katrin Offe; Marla Gearing; Howard D Rees; Guofu Fang; Craig J Heilman; Chica Schaller; Hideaki Bujo; Allan I Levey; James J Lah
Journal:  Arch Neurol       Date:  2004-08

Review 7.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

8.  Sorl1 as an Alzheimer's disease predisposition gene?

Authors:  Jennifer A Webster; Amanda J Myers; John V Pearson; David W Craig; Diane Hu-Lince; Keith D Coon; Victoria L Zismann; Thomas Beach; Doris Leung; Leslie Bryden; Rebecca F Halperin; Lauren Marlowe; Mona Kaleem; Matthew J Huentelman; Keta Joshipura; Douglas Walker; Christopher B Heward; Rivka Ravid; Joseph Rogers; Andreas Papassotiropoulos; John Hardy; Eric M Reiman; Dietrich A Stephan
Journal:  Neurodegener Dis       Date:  2007-11-01       Impact factor: 2.977

9.  Implication of sex and SORL1 variants in italian patients with Alzheimer disease.

Authors:  Elena Cellini; Andrea Tedde; Silvia Bagnoli; Silvia Pradella; Silvia Piacentini; Sandro Sorbi; Benedetta Nacmias
Journal:  Arch Neurol       Date:  2009-10

10.  Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues.

Authors:  Colton Linnertz; Laura Saucier; Dongliang Ge; Kenneth D Cronin; James R Burke; Jeffrey N Browndyke; Christine M Hulette; Kathleen A Welsh-Bohmer; Ornit Chiba-Falek
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240

View more
  13 in total

1.  Alzheimer disease (AD) specific transcription, DNA methylation and splicing in twenty AD associated loci.

Authors:  Crystal Humphries; Martin A Kohli; Patrice Whitehead; Deborah C Mash; Margaret A Pericak-Vance; John Gilbert
Journal:  Mol Cell Neurosci       Date:  2015-05-21       Impact factor: 4.314

2.  Novel susceptibility loci for Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Future Neurol       Date:  2015-12

3.  Group sparse reduced rank regression for neuroimaging genetic study.

Authors:  Xiaofeng Zhu; Heung-Il Suk; Dinggang Shen
Journal:  World Wide Web       Date:  2018-09-17       Impact factor: 2.716

4.  Low-Rank Graph-Regularized Structured Sparse Regression for Identifying Genetic Biomarkers.

Authors:  Xiaofeng Zhu; Heung-Il Suk; Heng Huang; Dinggang Shen
Journal:  IEEE Trans Big Data       Date:  2017-08-04

5.  An alternative transcript of the Alzheimer's disease risk gene SORL1 encodes a truncated receptor.

Authors:  Jenny Blechingberg; Annemarie Svane Aavild Poulsen; Mads Kjølby; Giulia Monti; Mariet Allen; Anne Kathrine Ivarsen; Sarah J Lincoln; Gangadaar Thotakura; Christian B Vægter; Nilüfer Ertekin-Taner; Anders Nykjær; Olav M Andersen
Journal:  Neurobiol Aging       Date:  2018-06-28       Impact factor: 4.673

6.  Sortilin receptor 1 predicts longitudinal cognitive change.

Authors:  Chandra A Reynolds; Catalina Zavala; Margaret Gatz; Loryana Vie; Boo Johansson; Bo Malmberg; Erik Ingelsson; Jonathan A Prince; Nancy L Pedersen
Journal:  Neurobiol Aging       Date:  2013-01-11       Impact factor: 4.673

7.  Neuroprotective effects of farnesene against hydrogen peroxide-induced neurotoxicity in vitro.

Authors:  Hasan Turkez; Piera Sozio; Fatime Geyikoglu; Abdulgani Tatar; Ahmet Hacimuftuoglu; Antonio Di Stefano
Journal:  Cell Mol Neurobiol       Date:  2013-10-09       Impact factor: 5.046

8.  Protective effects of cyclosativene on H2O 2-induced injury in cultured rat primary cerebral cortex cells.

Authors:  Hasan Turkez; Basak Togar; Antonio Di Stefano; Numan Taspınar; Piera Sozio
Journal:  Cytotechnology       Date:  2014-02-04       Impact factor: 2.058

9.  Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells.

Authors:  Jessica E Young; Jonathan Boulanger-Weill; Daniel A Williams; Grace Woodruff; Floyd Buen; Arra C Revilla; Cheryl Herrera; Mason A Israel; Shauna H Yuan; Steven D Edland; Lawrence S B Goldstein
Journal:  Cell Stem Cell       Date:  2015-03-12       Impact factor: 25.269

10.  The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespan.

Authors:  D Felsky; P Szeszko; L Yu; W G Honer; P L De Jager; J A Schneider; A K Malhotra; T Lencz; T Ikuta; J Pipitone; M M Chakravarty; N J Lobaugh; B H Mulsant; B G Pollock; J L Kennedy; D A Bennett; A N Voineskos
Journal:  Mol Psychiatry       Date:  2013-10-29       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.